Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Rat Model Market, by Technology
1.4.2 LAMEA Rat Model Market, by Type
1.4.3 LAMEA Rat Model Market, by Service
1.4.4 LAMEA Rat Model Market, by Application
1.4.5 LAMEA Rat Model Market, by End-use
1.4.6 LAMEA Rat Model Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Rat Model Market by Technology
3.1 LAMEA CRISPR/CAS & Others Market by Country
3.2 LAMEA Nuclear transferase Market by Country
3.3 LAMEA Embryonic Stem Cell & Microinjection Market by Country
Chapter 4. LAMEA Rat Model Market by Type
4.1 LAMEA Outbred Market by Country
4.2 LAMEA Hybrid Market by Country
4.3 LAMEA Knockout Market by Country
4.4 LAMEA Inbred Market by Country
4.5 LAMEA Immunodeficient Market by Country
4.6 LAMEA Conditioned Market by Country
Chapter 5. LAMEA Rat Model Market by Service
5.1 LAMEA Breeding Market by Country
5.2 LAMEA Genetic testing Market by Country
5.3 LAMEA Cryopreservation Market by Country
5.4 LAMEA Re-derivation Market by Country
5.5 LAMEA Quarantine Depending & Others Market by Country
Chapter 6. LAMEA Rat Model Market by Application
6.1 LAMEA Toxicology Market by Country
6.2 LAMEA Oncology Market by Country
6.3 LAMEA Immunology Market by Country
6.4 LAMEA Neurology & Others Market by Country
Chapter 7. LAMEA Rat Model Market by End-use
7.1 LAMEA CROs Market by Country
7.2 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
7.3 LAMEA Academic & Research Institutes Market by Country
Chapter 8. LAMEA Rat Model Market by Country
8.1 Brazil Rat Model Market
8.1.1 Brazil Rat Model Market by Technology
8.1.2 Brazil Rat Model Market by Type
8.1.3 Brazil Rat Model Market by Service
8.1.4 Brazil Rat Model Market by Application
8.1.5 Brazil Rat Model Market by End-use
8.2 Argentina Rat Model Market
8.2.1 Argentina Rat Model Market by Technology
8.2.2 Argentina Rat Model Market by Type
8.2.3 Argentina Rat Model Market by Service
8.2.4 Argentina Rat Model Market by Application
8.2.5 Argentina Rat Model Market by End-use
8.3 UAE Rat Model Market
8.3.1 UAE Rat Model Market by Technology
8.3.2 UAE Rat Model Market by Type
8.3.3 UAE Rat Model Market by Service
8.3.4 UAE Rat Model Market by Application
8.3.5 UAE Rat Model Market by End-use
8.4 Saudi Arabia Rat Model Market
8.4.1 Saudi Arabia Rat Model Market by Technology
8.4.2 Saudi Arabia Rat Model Market by Type
8.4.3 Saudi Arabia Rat Model Market by Service
8.4.4 Saudi Arabia Rat Model Market by Application
8.4.5 Saudi Arabia Rat Model Market by End-use
8.5 South Africa Rat Model Market
8.5.1 South Africa Rat Model Market by Technology
8.5.2 South Africa Rat Model Market by Type
8.5.3 South Africa Rat Model Market by Service
8.5.4 South Africa Rat Model Market by Application
8.5.5 South Africa Rat Model Market by End-use
8.6 Nigeria Rat Model Market
8.6.1 Nigeria Rat Model Market by Technology
8.6.2 Nigeria Rat Model Market by Type
8.6.3 Nigeria Rat Model Market by Service
8.6.4 Nigeria Rat Model Market by Application
8.6.5 Nigeria Rat Model Market by End-use
8.7 Rest of LAMEA Rat Model Market
8.7.1 Rest of LAMEA Rat Model Market by Technology
8.7.2 Rest of LAMEA Rat Model Market by Type
8.7.3 Rest of LAMEA Rat Model Market by Service
8.7.4 Rest of LAMEA Rat Model Market by Application
8.7.5 Rest of LAMEA Rat Model Market by End-use
Chapter 9. Company Profiles
9.1 Charles River Laboratories International, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Recent strategies and developments:
9.1.4.1 Acquisition and Mergers:
9.2 Laboratory Corporation of America Holdings
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Recent strategies and developments:
9.2.4.1 Acquisition and Mergers:
9.3 Inotiv, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.4 genOway
9.4.1 Company Overview
9.4.2 Financial Analysis
9.5 Janvier Labs
9.5.1 Company Overview
9.6 Taconic Biosciences, Inc. (H.I.G. Capital)
9.6.1 Company Overview
9.7 TransViragen, Inc.
9.7.1 Company Overview
9.8 Biomedical Research Models, Inc. (Biomere)
9.8.1 Company Overview
9.9 Cyagen Biosciences
9.9.1 Company Overview
Unique Offerings 